<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>135(7)</volume><submitter>Strati P</submitter><funding>NCI NIH HHS</funding><journal>Blood</journal><pagination>510-513</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7019190</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.</pubmed_title><pmcid>PMC7019190</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><pubmed_authors>Schlette EJ</pubmed_authors><pubmed_authors>Solis Soto LM</pubmed_authors><pubmed_authors>Jain N</pubmed_authors><pubmed_authors>Kim E</pubmed_authors><pubmed_authors>Wistuba II</pubmed_authors><pubmed_authors>Estrov Z</pubmed_authors><pubmed_authors>Ferrajoli A</pubmed_authors><pubmed_authors>Sivina M</pubmed_authors><pubmed_authors>Thompson PA</pubmed_authors><pubmed_authors>Kantarjian H</pubmed_authors><pubmed_authors>Duenas DE</pubmed_authors><pubmed_authors>Burger JA</pubmed_authors><pubmed_authors>Keating MJ</pubmed_authors><pubmed_authors>Wierda WG</pubmed_authors><pubmed_authors>Strati P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Feb</publication><modification>2025-04-27T01:53:02.809Z</modification><creation>2025-02-19T04:52:16.959Z</creation></dates><accession>S-EPMC7019190</accession><cross_references><pubmed>31895947</pubmed><doi>10.1182/blood.2019003570</doi></cross_references></HashMap>